Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Shares Outstanding (Diluted Average) (2018 - 2025)

Quantum Biopharma's Shares Outstanding (Diluted Average) history spans 8 years, with the latest figure at $3.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed N/A to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a N/A change, with the full-year FY2025 number at $3.3 million, changed N/A from a year prior.
  • Shares Outstanding (Diluted Average) hit $3.3 million in Q4 2025 for Quantum Biopharma, down from $7.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for QNTM hit a ceiling of $39998.8 billion in Q1 2022 and a floor of $130000.0 in Q2 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $15074.8 billion across 5 years, with a median of $27.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): crashed 100.0% in 2023 and later surged 5076.92% in 2025.
  • Tracing QNTM's Shares Outstanding (Diluted Average) over 5 years: stood at $34.9 million in 2021, then skyrocketed by 111283105.91% to $38888.2 billion in 2022, then plummeted by 100.0% to $27.2 million in 2023, then tumbled by 59.29% to $11.1 million in 2024, then crashed by 70.29% to $3.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for QNTM at $3.3 million in Q4 2025, $7.5 million in Q3 2025, and $6.7 million in Q2 2025.